HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania
Rationale & Objective: Longitudinal research on chronic kidney disease (CKD) in sub-Saharan Africa is sparse, especially among people living with HIV (PLWH).
Nicholas L.S. Roberts +11 more
doaj +1 more source
ObjectivesTo systematically evaluate the efficacy and safety of tenofovir and entecavir in chronic hepatitis B-related cirrhosis.MethodsA comprehensive search was conducted in databases including PubMed, Web of Science, Embase and Cochrane Library from ...
Lu Cao +4 more
doaj +1 more source
BackgroundOver the past several years, there have been several changes affecting the available options for oral HIV preexposure prophylaxis, including approvals for tenofovir alafenamide with emtricitabine in 2019 and a generic formulation of tenofovir ...
Elisabeth Merchant +3 more
doaj +1 more source
Correction: tenofovir disoproxil fumarate [PDF]
openaire +1 more source
Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study. [PDF]
Lim J, Yang J, Kim YJ, Kim HJ, Choi J.
europepmc +1 more source
Vaginal Microbiota and Cytokines Among Pregnant and Breastfeeding Women in Clinical Trials of the Dapivirine Vaginal Ring and Oral Tenofovir Disoproxil Fumarate/Emtricitabine. [PDF]
Petrina MAB +10 more
europepmc +1 more source
Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine. [PDF]
Namvaran A +10 more
europepmc +1 more source
HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV. [PDF]
Lapadula G +11 more
europepmc +1 more source
Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]
Cox S +7 more
europepmc +1 more source
The efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in treatment-naïve and treatment-experienced patients with HIV. [PDF]
Yang H, Li M, Liu Q, Zeng Q, Yuan J.
europepmc +1 more source

